Literature DB >> 6149129

Is the feeling of cold extremities experienced by hypertensive patients due to their disease or their treatment?

M J VandenBurg, S J Evans, W D Cooper, F Bradshaw, W J Currie.   

Abstract

Patients with essential hypertension were interviewed prior to entering therapeutic studies in general practice. Patients' age, sex and details of antihypertensive therapy (if any) were noted, as were their spontaneously reported symptoms. Complaints of cold extremities were highest in those taking a beta-blocker (4.1%). Those untreated or taking other therapies complained less often. Those patients taking a beta-blocker with ISA complained less often (3.1%) of cold extremities than those taking a beta-blocker without ISA (5.2%).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149129

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  EFFECTS OF GUANETHIDINE, RESERPINE, AND METHYLDOPA ON REFLEX VENOUS AND ARTERIAL CONSTRICTION IN MAN.

Authors:  D T MASON; E BRAUNWALD
Journal:  J Clin Invest       Date:  1964-07       Impact factor: 14.808

2.  Effects of cold exposure on blood pressure, heart rate and forearm blood flow in normotensives during selective and non-selective beta-adrenoceptor blockade.

Authors:  H Houben; T Thien; G Wijnands; A Van't Laar
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

3.  Effect of acute oral beta adrenergic blockade on muscle blood flow in man.

Authors:  R S Smith; D J Warren
Journal:  Cardiovasc Res       Date:  1982-04       Impact factor: 10.787

Review 4.  Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: the key role of vascular resistance changes in relation to partial agonist activity.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  J Cardiovasc Pharmacol       Date:  1983       Impact factor: 3.105

5.  A comparison of two beta-blocking drugs in patients with Raynaud's phenomenon.

Authors:  G Holti
Journal:  Practitioner       Date:  1982-04

Review 6.  Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  Drugs       Date:  1974       Impact factor: 9.546

7.  Effect of beta-adrenoceptor antagonists on prevalence of peripheral vascular symptoms in hypertensive patients.

Authors:  J A Steiner; R Cooper; K McPherson; A J Riley
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

8.  Beta-adrenergic vasodilator mechanism in the finger.

Authors:  R A Cohen; J D Coffman
Journal:  Circ Res       Date:  1981-11       Impact factor: 17.367

9.  A comparison of the effects of propranolol and oxprenolol on forearm blood flow and skin temperature.

Authors:  M J Vandenburg; C Conlon; J M Ledingham
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

10.  The acute and chronic effect of oxprenolol and propranolol on peripheral blood flow in hypertensive patients.

Authors:  M J Vandenburg
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

View more
  3 in total

Review 1.  Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis.

Authors:  Charles Khouri; Thomas Jouve; Sophie Blaise; Patrick Carpentier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-05-31       Impact factor: 4.335

Review 2.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

3.  Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.

Authors:  Susoma Jannat; Anand Balupuri; Md Yousof Ali; Seong Su Hong; Chun Whan Choi; Yun-Hyeok Choi; Jin-Mo Ku; Woo Jung Kim; Jae Yoon Leem; Ju Eun Kim; Abinash Chandra Shrestha; Ha Neul Ham; Kee-Ho Lee; Dong Min Kim; Nam Sook Kang; Gil Hong Park
Journal:  Exp Mol Med       Date:  2019-02-12       Impact factor: 8.718

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.